CRISPR Technology Market, 2027 -

DUBLIN--()--The "Global CRISPR Technology Market - Focus on Product, Applications, Geographical Analysis, Industry Insights and Competitive Landscape - Analysis and Forecast (2018-2027)" report has been added to's offering.

Global CRISPR Technology Market Expected to Reach $10.55 Billion by 2027

The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, haemophilia, and sickle cell anaemia, among others. The increasing prevalence of genetic disorders is promoting the growth of the CRISPR technology, for better treatment and improved quality of life of patients.

The CRISPR technology include designing tools, library, control kits, plasmids, vectors, proteins, gRNA and other products to perform the desired experiment and study the obtained results. Currently, CRISPR technology is considered a valuable tool for the biotechnology and biopharmaceutical companies to conduct cost effective and highly efficient genome editing procedures. Moreover, advancements of CRISPR technology reduced turn-around time and complexity of genome editing process.

The CRISPR technology provides several opportunities to develop the one-time treatment for various rare genetic disorders. The pharmaceutical industry is witnessing the growth of pipeline of candidates developed using CRISPR technology. Several biopharmaceutical companies are now indulging in the research and development of such CRISPR based therapies. Furthermore, the advent of genome editing technologies in molecular research has enabled the companies to target the root cause of genetic and chronic diseases, with one-time procedure and develop gene therapeutics to remain competitive in the market.

The purpose of this study is to gain a holistic view of the CRISPR technology market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the products associated with the global CRISPR technology market, across different regions. The market has been segmented into product', application', and regions'. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global CRISPR technology market with the help of the key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion.

The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.

Key Topics Covered:

1 Market Overview

2 Market Dynamics

3 Competitive Landscape

4 Industry Insights

5 Global CRISPR Technology Market, by Product

6 Global CRISPR Technology Market, by Application

7 Global CRISPR Technology Market, by Region

8 Company Profiles

9 Report Scope & Methodology

Companies Mentioned

  • Agilent Technologies, Inc.
  • Applied StemCell, Inc.
  • Cellecta, Inc.
  • Corporate Summary
  • Dharmacon, Inc.
  • DiaCarta, Inc.
  • EdiGene, Inc.
  • GeneCopoeia, Inc.
  • GeneScript
  • Genedata AG
  • Global Presence
  • Integrated DNA Technologies (IDT), Inc.
  • Mirus Bio LLC
  • New England Biolabs
  • OriGene Technologies, Inc.
  • Oxford Genetics Ltd.
  • Rockland Immunochemicals, Inc.
  • Sigma Aldrich Corporation (A Subsidiary of Merck KGaA)
  • Synthego Corporation
  • System Biosciences, LLC
  • Takara Bio USA Inc. (A Subsidiary of Takara Bio Inc.)
  • Thermo Fisher Scientific Inc.
  • Transposagen Biopharmaceuticals
  • TransOMIC technologies inc.

For more information about this report visit

Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics

Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics